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ABSTRACT
Objective: The purpose of this study was to compare body weight and composition
(%fat, fat mass, and fat-free mass) in neonates born to mothers with a normal pre-gravid
BMI (<25 kg/m2) versus neonates born to mothers with an overweight/obese pre-gravid
BMI (25 kg/m2).
Study Design: Seventy-two neonates (33 from normal mothers and 39 from
overweight/obese mothers) of singleton pregnancies with normal glucose tolerance had
their body weight and body composition assessed by air-displacement plethysmography.
Results: After controlling for neonate age at time of testing, significant differences were
found between groups for %fat (12.5 ± 4.2 % vs. 13.6 ± 4.3 %; P0.0001), fat mass
(414.1 ± 264.2 g vs. 448.3 ± 262.2 g; P0.05) and fat-free mass (3310.5 ± 344.6 g vs.
3162.2 ± 343.4 g; P0.05), with no significant differences between birth length (50.7 ±
2.6 cm vs. 49.6 ± 2.6 cm; P=0.08) or birth weight (3433.0 ± 396.3 g vs. 3368.0 ± 399.6
g; P = 0.44).
Conclusions: Neonates born to mothers who have a normal BMI have significantly less
total and relative fat, and more fat-free mass than neonates born to overweight/obese
mothers. Though preliminary, these data suggest that the antecedents of future disease
risk (e.g. cardiovascular disease, diabetes, and obesity) occur early in life.
1CHAPTER I
INTRODUCTION
Adult obesity has risen rapidly over the past thirty years with 1 in 3 adults
classified as obese (1). Overweight and obesity have been linked to the development of
disorders such as hypertension, dyslipidemia and insulin resistance, referred to
collectively as the metabolic syndrome (2). The primary outcome of the metabolic
syndrome is cardiovascular disease leading to impaired health and possible early
mortality. The same staggering statistics and disorders are found in overweight children
and adolescents as well. Currently, 30% of children are classified as at risk for
overweight while 17% are overweight (1) and more startling is the greatest increase in
overweight was seen in preschool children (3).
The complications of overweight in children are similar to those found for adults
(4, 5). Overweight in children is related to dyslipidemia, elevated blood pressure and
impaired glucose tolerance (6, 7). Unfortunately, the early onset of type 2 diabetes is
associated with a more aggressive type of cardiovascular disease later in life (8). Obesity
alone is attributed to an annual 300,000 deaths per year while type 2 diabetes is the 6th
leading cause of death (9, 10).
With the rapid increases in obesity rates, a first ever decline in life expectancy is
predicted, especially among young obese adults (11, 12). Due to its detrimental health
effects, the root cause of the rise in obesity and the related disorders in adults and
overweight in children is vehemently being studied. Though the obesity crisis is clearly
visible, the mechanisms underlying the development of obesity are poorly understood.
2In an attempt to discern critical periods for obesity development, recent research
has focused on the intrauterine environment and its importance on obesity development
and the metabolic outcome of the infant (13). The Barker Hypothesis or “fetal origins
hypothesis” (14) proposes that diseases manifesting in childhood and adulthood are
actually “programmed” from restraint of growth during fetal life and infancy.
“Programmed” refers to the induction, deletion or impairment of development of organ
structure by an early insult or stimulus during gestation or critical periods of early life
that cause permanent or long term changes in the structure or function of an organism
(15, 16).
The intrauterine environment is assessed crudely by the birth weight of the
infant. However there are issues when using birth weight as an indicator of nutrition
status (17). For instance, low birth weight during gestation is defined as a birth weight
below 2500 grams or a preset percentile such as 3rd, 5th or 10th percentile (18). However,
just using these parameters does not distinguish how these infants arrived at this birth
weight. For example, there may have been an impact of poor maternal nutrition or
simply these babies may have reached their genetic growth potential (17). At this time, a
routine clinical measure does not exist to distinguish these factors.
The perinatal mortality rate is six to ten times higher in low birth weight infants
than those infants born at a normal birth weight (17). Small birth size and disproportion
in length, head size and weight indicate an inadequate supply of nutrients and oxygen
during stages of gestation (14). These abnormalities in growth reflect the adaptations the
fetus made to survive during development. However the conditions the fetus is exposed
to during development, under or over-nutrition may not be permanent. Instead, many
3times the environment is one of nutrition abundance. On the converse, over-nutrition
during gestation results in fetal overgrowth termed macrosomia which is defined by a
birth weight greater than 4000 grams or large for gestational age where weight exceeds
the 90th percentile based on population norms. A high birth weight due to over-nutrition
during gestation increases the chance of obesity development, type 2 diabetes and the
metabolic syndrome later in life (13).
Low birth weight is associated with the development of respiratory distress
syndrome, hypoglycemia, hypocalcemia, hyponatremia and coronary heart disease (14,
18). Additionally, studies have identified a high birth weight relating to an increased risk
of overweight in adolescence (19-21). Other studies have identified a low birth weight
relating to development of type 2 diabetes, increased risk of obesity development and the
metabolic syndrome (19, 22-25).
Furthermore, research has shown a direct relationship between maternal obesity
and the development of obesity and metabolic disorders in offspring (26-30). However,
scarcity in food in developed nations is not currently a problem, rather there are
conditions of an abundance of food. In infants exposed to an adverse intrauterine
environment leading to a low birth weight, an over abundance of food presents a
problem. Their bodies were programmed to survive and to efficiently use all nutrients.
Therefore, their bodies lack the ability to handle an abundance of nutrients therefore
increasing the risk of coronary heart disease, diabetes and obesity stemming from the
adaptations to survive developed during gestation (15).
4Even though epidemiological studies have suggested a relationship between birth
weight and development of disease in adulthood, some research finds no relationship to
birth weight and future disease development in the offspring (31-35). Studies examining
subjects exposed to malnutrition during pregnancy due to famine during the sieges of
Leningrad (35) and Finland (33) found no effect of the famine on disease development
in adulthood. Other research (32) suggests inadequate nutrition during pregnancy may
affect later health in adulthood indirectly and not directly by affecting birth weight of the
offspring. Therefore, solely using birth weight as an indicator of the relationship may
underestimate the true association.
The prevalence of obesity in American women aged 20-39 during reproductive
years is 30% (1), so many females enter into pregnancy in an obese state putting
themselves at risk for metabolic complications and poor pregnancy outcomes (36, 37). In
the United States, the rate of low birth weight is fairly low, occurring only during 5% of
all pregnancies (38). In fact, over the last 25 years, the mean weight of females at their
first prenatal visit has increased 20% as well as the percent of women with a BMI
greater than 29 kg/m2 (39). Studies in both North America and Europe have reported an
increase in mean birth weight, with those greater than the 90th percentile for gestational
age or classified as macrosomic increasing the most (40, 41).
Furthermore, recent work has shed light on possible physiological outcomes of
the infant due to maternal over-nutrition. In an Italian population, maternal
hypercholesterolemia was related to increased rates of fatty streaks of the fetus in a post
mortem study (42, 43). Studies of Pima Indians shows a high likelihood of maternal
diabetes being passed to the offspring (44). Research has yet to elucidate the exact
5physiological mechanisms underlying changes in the offspring due to maternal over
nutrition during pregnancy.
Maternal overnutrition is suggested to affect the development of several systems
and organs in the offspring. They include the appetite regulating network (45-50), the
cardiovascular system (42, 51, 52) and the pancreas affecting insulin sensitivity (51, 53,
54). In rodent models that explored effects of development of appetite control, research
shows specific areas of the brain to be affected (55, 56). Therefore, in cases of over-
nutrition, the satiety signals are not recognized (46, 55, 56). Maternal over-nutrition (53,
54) is also related to fetal insulin resistance, greater circulating levels of leptin and
higher levels of resting glucose and insulin in offspring. Impairment of pancreatic beta
cells and structural changes in the pancreas has been found. Regulation of blood pressure
is also affected by in utero exposure to maternal over nutrition (52, 57) through an
inability of baroreceptors to function and control blood pressure (57). Additionally,
vasodilation in offspring is blunted, the fatty acid content of the aorta was abnormal and
elevated levels of triglycerides and reduced levels of HDL were detected in offspring of
overnourished mothers (52).
The divergent views regarding the relationship between an adverse intrauterine
environment and the development of obesity and related disorders in the infant
emphasizes the need to further understand how maternal BMI impacts outcomes in the
offspring. Research suggests a relationship between maternal obesity and large for
gestational age and later development of obesity in the offspring (30, 58). However, only
one study has quantified infant body composition related to maternal BMI (59). The
purpose of this study was to compare infant body composition and body weight of
6mothers categorized as normal and overweight/obese based on pre-gravid body mass
index (BMI).
Purposes
1. The purpose of this study was to compare birth weight in neonates from mothers
who are classified as having either a normal (<25 kg/m2) or overweight/obese (25
kg/m2) pre-gravid BMI.
2. A second purpose was to compare body composition in neonates from mothers who
are classified as having either a normal (<25 kg/m2) or overweight/obese (25
kg/m2) pre-gravid BMI.
Research Questions
1. Does neonatal birth weight differ between mothers who have a normal (<25 kg/m2)
or overweight/obese (25 kg/m2) pre-gravid BMI?
2. Does neonatal percent body fat differ between mothers who have a normal (<25
kg/m2) or overweight/obese (25 kg/m2) pre-gravid BMI?
3. Does neonatal total fat mass differ between mothers who have a normal (<25 kg/m2)
or overweight/obese (25 kg/m2) pre-gravid BMI?
4. Does neonatal fat-free mass differ between mothers who have a normal (<25 kg/m2)
or overweight/obese (25 kg/m2) pre-gravid BMI?
Hypotheses
1. Neonates from overweight/obese mothers will weigh significantly more than
neonates born to normal pre-gravid BMI mothers.
2. Neonates from overweight/obese mothers will have a significantly higher percent
body fat than neonates born to normal pre-gravid BMI mothers.
73. Neonates from overweight/obese mothers will have significantly higher fat mass
than neonates born to normal pre-gravid BMI mothers.
4. Neonates from overweight/obese mothers will have significantly lower fat-free mass
than neonates born to normal pre-gravid BMI mothers.
Significance of the Study
While birth weight provides a crude, simple and indirect assessment of
intrauterine environment, body composition assessment provides a more detailed
understanding of the relationship between birth weight and obesity programming in early
life.
Delimitations
1. Healthy male and female full-term infants with a gestational age of >37 weeks and
42 weeks.
2. Infants whom were 35 days old.
3. Mother at the time of delivery is between the ages of 18-45 years old.
4. Infants with a prolonged medical stay defined as >4 days.
5. Tobacco use by the mother during pregnancy.
6. Excessive alcohol consumption during pregnancy defined as >1 drink a week.
7. Infants with presumed or known chromosomal or severe congenital abnormalities
will not be allowed to participate.
8. Infants from mothers with type 1, type 2 or gestational diabetes.
Limitations
1. The subject sample was limited to the surrounding communities of Oklahoma City,
Oklahoma.
82. Many in the subject sample may be affiliated with University of Oklahoma Health
Sciences Center clinics and uninsured.
Assumptions
1. All mothers reported medical history concerning birth (length of gestation, pre-
gravid body weight and height, pregnancy weight gain) honestly and accurately.
2. Infants are healthy and free of disorders that could affect intrauterine growth and
metabolism.
Operational Definitions
1. Pre-gravid – Prior to pregnancy.
2. Gestation – During pregnancy.
3. Prenatal – Occurring, existing, or performed before birth.
4. Pea Pod® - Trademark name for the only commercially available system to assess
infant body composition using air displacement plethysmography made by Life
Measurement Incorporated, Concord, CA.
5. Plethysmography – A technique referring to the measurement of size or volume by
using the pressure volume relationship (60).
6. Macrosomia – A birth weight greater than 4000 g (18).
7. Large for gestational age – A birth weight that exceeds the 90th percentile for
population based norms (18).
8. At risk for obesity – A length for height greater than or equal to the 95th percentile.
9CHAPTER II
REVIEW OF LITERATURE
The intention of this study was to examine the effects of an adverse intrauterine
environment on development of obesity in infants. The primary purpose of this study
was to compare infant body weight and composition from mothers who have a normal or
overweight/obese pre-gravid BMI.
Assessment of Infant Body Composition
Assessing body composition in infants using sophisticated methods presents
technological, ethical and practical limitations therefore few research studies have
thoroughly explored this topic. Though with the concurrent epidemic in childhood
obesity and type 2 diabetes, the knowledge gained through assessment of infant body
composition could be beneficial to determine if early life events influence or are related
to the development of these disorders. Though birth weight does provide a crude
estimate of conditions experienced by the infant in utero, quantification of fat and fat-
free mass may provide a description of any underlying relationships.
All body composition methods assess body fat indirectly and therefore are based
on theoretical models (61). Special populations such as infants could potentially violate
the underlying assumptions of the multi-component models. Thus the accuracy of the
technique to assess body composition depends on the model and the associated
assumptions. When assessing body composition in infants, special consideration must be
taken into account when selecting a technique. Various methods have been used to
assess body composition in infants such as anthropometry (62-66), magnetic resonance
imaging (MRI) (67), total body water (TBW) (67-70), total body potassium (TBK) (68,
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70), total body electrical conductivity (TOBEC) (64, 68, 69, 71, 72), dual energy x-ray
absorptiometry (DXA) (62, 65, 66, 68, 73, 74) and densitometry using air displacement
plethysmography (75-78). Research has suggested that densitometry is a method that
holds promise for a safe, quick and easy assessment of infant body composition (75).
The only method based on densitometry and used for infant body composition
assessment is the Pea Pod® using air displacement (75). The following paragraphs will
summarize research studies using the various methods described previously to assess
infant body composition.
A very simple method to assess changes in body mass is measuring length, body
weight or skeletal width (61). Changes in anthropometrics are assumed to represent
changes in fat mass and fat-free mass however circumference or skinfold thickness are
needed to better distinguish changes in fat and fat-free mass (79). Numerous studies
have validated various anthropometrics to either total body water (80, 81), total body
electric conductivity (64, 72, 80, 81) or dual energy x-ray absorptiometry (62, 65, 66).
Davies and Lucas (81) validated the Quetelet’s index with total body water in
male and female infants at 5 and 11 weeks. They found Quetelet’s index to be a poor
predictor of body fatness. In a second study by the same group (80), they compared
skinfold thickness to total body water in infants at 5, 11 and 26 weeks and again found
skinfold thickness to be an inaccurate method to predict fat mass. Total body water
(TBW) has also been used to validate the use of skinfold thickness to estimate fat mass
(63). Poor agreement was found with TBW and skinfold thickness overestimated body
fat at low ranges of body fat and underestimated body fat at higher values of body fat.
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Other research compared anthropometric predictive equations by Westrate et al.
(82) and Dauncey et al. (83) to TOBEC in 435 infants (64). Both equations showed poor
agreement with fat mass results from TOBEC. However, research by de Bruin et al. (72)
compared upper-arm anthropometry, Quetelet’s index, weight by length and skinfold
circumferences at five sites (biceps, triceps, subscapular, suprailiac and quadriceps) to
TOBEC in 435 infants. TOBEC fat mass measurements correlated strongest with weight
for length and calf circumferences however, researchers recommended using any of the
anthropometric methods as only rough estimates of fat mass in infants.
Dual energy x-ray absorptiometry (DXA) has been used to assess the ability of
anthropometric measures to assess fat mass in infants (62, 65, 66). In contrast to other
studies validating anthropometrics, these studies all found agreement between their
measurements and DXA. Koo et al. (66) assessed 214 infants and found weight and
length best agreed with DXA for prediction of fat mass (adjusted R2>0.85). Similarly,
two studies comparing weight, length and skinfold thickness at the triceps, biceps,
suprailiac and subscapular and found skinfold thickness best agreed with DXA (62, 65).
Butte et al. (68) compared TBW, TBK, TOBEC and DXA in 76 healthy term infants at
various time points during the first two years of life. Significant differences were found
between all methods and wide limits of agreement suggest these methods cannot be used
interchangeably and researchers concluded further development and validation of body
composition methods in infants is needed.
Air-displacement holds promise as a simple, quick and reliable method to assess
body composition in infants (75). Sold commercially as the Pea Pod®, measurement of
body composition involves assessment of body mass and body volume. Completion of
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the entire testing procedure can be done in five minutes. Since being introduced in 2003,
few studies have been done using air displacement in infants (76-78). Sainz and Urlando
(76) used 24 phantoms made from pig muscle and fat to assess the precision and
accuracy of the Pea Pod® compared to chemical analysis and hydrostatic weighing. No
differences were found between the Pea Pod® and chemical analysis with mean percent
fat values of 18.55% and 18.59%, respectively. Percent fat measurements from all three
methods were highly correlated (r>0.90; P<0.0001). Using regression analysis with
chemical analysis as the reference method, no difference was found from the line of
identity indicating agreement between percent measures by the Pea Pod® and chemical
analysis. Bias was assessed between Pea Pod® and chemical analysis with results
indicating high agreement and no systematic bias in differences across a wide range of
mass and percent fat ranges (76).
Yao et al. (78) assessed within and between day reliability in 17 infants on two
consecutive days. Results indicated the mean differences in percent fat for day one (-
0.39±0.81) and day two one (-0.27±0.97) were not different from zero and the percent
fat 95% limits of agreement for within and between day tests were narrow (-2.0-1.2 and -
2.2-1.7, respectively). Between and within day reliability as well as accuracy was also
assessed by a second study (77). No differences were found for percent fat between days
or within days (-0.5±1.21 %fat and 0.16±1.44 %fat, respectively). In addition to
assessing validity and reliability, accuracy of body fat measures from the Pea Pod® were
compared to body fat measures from TBW using deuterium (2H2O). No difference was
found between mean percent body fat from air displacement and TBW (20.32 %fat vs.
20.39 %fat). The 95% limits of agreement were calculated between the two methods (-
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6.84 %fat, 6.71 %fat) and were lower than reported for other methods to assess body
composition in infants. Regression analysis found high agreement (R2=0.76) between
methods and a low SEE (3.26) (77). Thus, the authors concluded air displacement is an
accurate and reliable method to assess body composition in infants.
Metabolic and Hormonal Occurrences and Disturbances during Pregnancy
During pregnancy, several complex hormonal and metabolic adaptations occur to
ensure proper growth and survival of the developing fetus (84). Human chorionic
gonadotropin, progesterone, estrogens, human chorionic somatomammotropin, prolactin,
relaxin and inhibins are a short list of hormones that increase and work to maintain the
pregnancy and ensure optimal growth. There are specific endocrine functions that
change during a normal pregnancy and possibly most significant are changes in the
function of the pancreas; specifically the beta cells (84). Maternal insulin sensitivity is
normal or even enhanced during the first trimester however, during the second and third
trimesters insulin sensitivity is greatly decreased (85). Catalano et al. estimated
reductions of insulin sensitivity by 47% in obese women and a 56% reduction in insulin
sensitivity in normal weight women (86, 87). Therefore in response to increased insulin
sensitivity, human chorionic somatomammotropin direct the beta cells to increase
production of insulin to compensate for this decline in insulin sensitivity. Furthermore,
estrogen, growth hormone, corticotropin-relasing hormone and progesterone allow
energy production utilization to shift from primarily carbohydrates to lipids thus making
glucose readily available to the fetus (85). Pregnancy is therefore characterized by
increases in blood glucose levels and modifications of circulating cholesterol,
triglycerides, free fatty acids and phospholipids. Several glucocorticoids are also
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elevated during this time and are thought to contribute to maternal adipose tissue gain
and mammary gland development (84). These metabolic adaptations are necessary to
support the increased energy demands during pregnancy as well as prepare the maternal
system for delivery and lactation (85).
When metabolic and hormonal adjustments fail to overcome insulin resistance
due to pregnancy and the beta cells cannot maintain maternal glucose within normal
values, gestational diabetes develops (88). Gestational diabetes is simply defined as any
degree of glucose intolerance first recognized during pregnancy (89). This type of
glucose intolerance affects approximately 7% of all pregnancies and can carry short and
long term complications (88). Those with gestational diabetes are at increased risk for
pregnancy induced hypertension, toxemia and delivery by caesarean section (88) as well
as subsequent development of type 2 diabetes (85).The infant of a gestational diabetic is
at increased risk for macrosomia, neonatal hypoglycemia, hyperbilirubinemia,
hypocalcemia and polycythemia (88).
Compounding the situation and effects of gestational diabetes is maternal obesity
(90). Though there are many associated risks during pregnancy with gestational diabetes,
maternal obesity can carry similar and independent risks. The prevalence of obesity in
women of reproductive age is 30% (1) therefore pre-gravid overweight is one of the
most common high risk obstetric complications (37). Many associate obesity as being
related to development of disorders later in life, however a small increase in weight prior
to pregnancy relates to increased risk for development of gestational diabetes and
hypertension during pregnancy (37).
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There are several obstetric complications that can develop during pregnancy due
to maternal obesity that can affect the health of the mother as well as the health of the
infant (90). Generally, complications during pregnancy are due to an excessive pre-
gravid BMI rather than excessive weight gain during pregnancy (90). There are
recommendations for healthy weight gain during pregnancy based on weight of the
mother before pregnancy. The Institute of Medicine recommends for women who enter
into pregnancy at a normal weight to gain 25-35 lbs, women who are overweight to gain
15-25 lbs and women who are obese to gain 15 lbs (91). Possibly more discerning than
weight gain, is fat mass changes during pregnancy. Ehrenberg et al. (92) examined
women by pre-gravid weight status to determine which grouped gained the greatest
percent body fat. Results found lean subjects gained greater percent fat compared to
obese subjects however similar amounts of fat mass and fat-free mass were gained (92).
Specific complications during pregnancy that can occur in overweight and obese
women include increase risk of miscarriage, gestational hypertension, pre-eclampsia and
gestational diabetes (90). Mothers who are obese prior to pregnancy or develop
gestational diabetes during pregnancy tend to have larger babies and therefore are at
increased risk for caesarean delivery and the associated morbidities of this type of
delivery (90). Aside from the risks presented to the mother’s health, there are fetal risks
associated with maternal obesity as well. Obese mothers are more likely to bear a child
with low Apgar scores, neural tube defects and macrosomia (37). The detection of fetal
abnormalities during gestation is difficult in women with increased central adiposity
possibly delaying necessary medical care. Due to women with a greater pre-gravid BMI
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giving birth to larger babies, there are long term health risks such as increased risk of
obesity, hypertension and diabetes for the infant in adulthood (19, 22).
Studies in both North America and Europe have reported an increase in mean
birth weight, with those greater than the 90th percentile for gestational age or classified
as macrosomic increasing the most (40, 41). Insulin resistance is normal during
pregnancy, however, in obese pregnancy women insulin resistance is increased even
greater (86, 87). Therefore, the fetus is exposed to all major fuel sources, glucose, free
fatty acids, ketones and amino acids. This is a major contributing factor to obese
pregnant women delivering infants that are large for gestational age (37). Furthermore,
increases in the flow and availability of substrates from the mother decreases release of
placental growth suppressive peptides. These peptides are responsible for enhancing
fetal growth rate through increasing expression of insulin like growth factors and
decreasing their binding proteins (93). Therefore, the increasing prevalence of
macrosomia in obese women is due to a shift and increase in fuel metabolism. In models
to predict macrosomia, the addition of hyperlipidemia further verifies large birth weights
therefore increased lipids, as well as increased glucose, contribute to large infants (93).
Fetal Programming of Obesity Development
Critical periods for obesity development have been identified; gestation, early
infancy, the period of adiposity rebound around 5 years and adolescence (13). As will be
discussed below with the fetal origins hypothesis, prenatal or perinatal undernutrition
can adversely impact the health outcome of the infant during adulthood (13). Studies of
pregnant women from times of war or famine provide insight into the effect of abnormal
nutrition on the health outcome of the infant (94). The prevalence of obesity was greatest
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in offspring conceived during the Dutch famine than those who were conceived before
of after.
Birth weight of the infant is used as a crude measure of the intrauterine
environment and research has shown a low or high birth weight is related to an increase
in the chance of obesity development, type 2 diabetes and the metabolic syndrome later
in life (19, 22-25). Maternal obesity is also related to the development of obesity and
metabolic disorders in the offspring (26-30). In addition, an altered maternal-fetal
glucose metabolism has been shown to influence infant birth weight and obesity
development as seen during gestational diabetes (20). Offspring exposed to an
intrauterine environment of gestational diabetes have an increased risk of developing
later obesity and type 2 diabetes (26, 28).
Though epidemiological studies have suggested a relationship between birth
weight and development of disease in adulthood, some research opposes these
hypotheses (31-35). Stanner et al. (35) studied 169 subjects exposed to famine during the
siege of Leningrad in 1941 to 1942. They compared three groups: subjects exposed to
famine in utero, subjects exposed to famine as infants and a subjects born at the same
time but outside of the area under siege. No differences were found between those
exposed to starvation in utero or during infancy for glucose tolerance, insulin
concentration or blood pressure. A relationship between blood pressure and adult obesity
was found in the first group suggesting famine exposure in utero and adult obesity acted
synergistically to increase hypertension development.
A similar study was performed to examine those exposed to famine in Finland
from 1866 to 1868 (33). Finnish vital statistics were used to compare those born before
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and after the famine to those born during the famine. Mortality was compared at age 17
years, 17 to 40 years, 60 years and 80 years. No difference in mortality was found
between the three groups at subsequent ages, including old age. A recent article by
Painter et al. (95) reports results from 975 subjects who survived the Dutch famine
between 1944 to 1945 and risk of coronary artery disease (CAD) development in
adulthood. Of the 975 subjects, only 83 subjects were diagnosed with CAD and overall
analysis showed a weak relationship between birth weight and CAD development.
However a subgroup analysis breaking subjects into five groups based on time of
exposure to famine found a difference based exposure rate for CAD development
compared to no famine exposure. Authors conclude a significant affect of malnutrition
and later CAD development in adulthood, though the small numbers within groups may
confound their conclusions.
Other researchers (32) suggest inadequate nutrition during pregnancy may affect
later health in adulthood indirectly and not directly by affecting birth weight of the
offspring. Therefore, solely using birth weight as an indicator of the relationship may
underestimate the true association. Furthermore, early research by Moulton used autopsy
of stillborn babies categorized by small-, appropriate- or large for gestational age to
quantify accretion of fetal fat (96). The lean body mass was relatively consistent
between all three groups; however the large for gestational age group had the greatest
amount of fat accretion. The divergent views regarding the relationship between an
adverse intrauterine environment on development of obesity and related disorders in the
infant emphasizes the need to further understand how maternal BMI impacts health of
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the offspring. At this time, only one study has quantified infant body composition and
used this information to discern a relationship with maternal BMI (59).
Disease Development Related to Low Birth Weight
With the prevalence of obesity and related disorders continually increasing over
the last thirty years in both adults and children, urgency has been placed to find cause for
these rapid changes with far reaching implications (1). Based on large cohort
epidemiological studies, the idea that the intrauterine environment impacts the
development of adult disease was developed (97-103). Within epidemiological studies, a
theme emerged; links were made between adult disorders and body size at birth. With
this idea, hypotheses were proposed by Hales and Barker termed the fetal or
developmental origins hypothesis (15). These hypotheses suggest that adult disease is a
result of growth restraint during gestation due to malnutrition of the mother or impaired
nutrient transfer to the fetus. Undernutrition is thought to cause an insult during a critical
period of early life to the fetus that leads to a “programmed” effect. “Programmed”
refers to the induction, deletion or impairment of development of organ structure by an
early insult or stimulus during gestation or critical periods of early life that are
permanent or cause long term changes in the structure or function of an organism (15,
16).
Fetus exposure to an intrauterine environment of undernutrition will result in
physiological adaptation to ensure survival (15). During adaptation, the fetus optimizes
the restricted nutrient supply by favoring the development of some organs over others
therefore preserving the development of critical organs such as the brain over the
development of less critical organs such as the pancreas, liver, kidneys and muscle. This
20
altered growth leads to changes in the metabolism, perfusion and innervation of
developing tissues (15). Critical periods for tissue growth and rapid cell division have
been identified where organs differentiate and mature for survival after birth. Exposure
to undernutrition during this time may have long lasting consequences on organ function
making the fetus susceptible to development of disease later in life during adulthood
(15).
Examples of organs hypothesized to be affected by undernutrition are the
pancreas and liver, both important for metabolic balance and the kidneys and circulatory
system, both important for blood pressure maintenance (15, 104). Specifically, the beta
cells of the pancreas are sensitive and damage to the vasculature and innervation of the
beta cells due to suboptimal nutrition, give rise to defects of structure and function of the
pancreas (15). This impairment results in insufficient insulin release causing
hyperglycemia and eventual beta cell burnout in efforts to control high blood glucose
concentrations (105). Therefore, impairment of the function of the pancreas results in a
predisposition for development of type 2 diabetes. This damage is exacerbated by age
and a natural decline in organ function. Furthermore, the body has programmed itself to
survive in an environment of little nutrition (15). However, lack of food is not currently
a problem in most developed nations; instead there is an abundance of food and a lack of
physical activity.
Fetal malnutrition is also related to a diminished development and function of
other organs such as the liver, kidneys and circulatory system involved in the control of
blood pressure (104). Infants who were malnourished in utero have a decline in the
number of nephrons (106) and elastin in the vessel walls leading to impairment of the
21
regulation of blood pressure (107). With a decline in the number of nephrons, an
increase in glomerular filtration rate in the remaining nephrons is increased due to the
diminished number (17). This results in an increased nephron flow and glomerular
volume resulting in focal glomerulosclerosis or nephron loss. The ultimate end result is
an inability to regulate increases in blood pressure and therefore hypertension develops
(17). Further evidence is found in ultrasound studies that have examined growth rates of
the fetal kidneys between small and appropriate for gestation age infants (108). Results
indicate the growth rate of the kidneys was slower in small for gestational age infants
and differences between groups were greatest between 26 and 34 weeks gestation.
Furthermore, differences in kidney size after birth was detected with smaller size
detected in small for gestational age infants compared to appropriate for gestational age
infants (108).
Other research regarding development of hypertension in adulthood found
impairment of endothelial dependent vasodilation mediated by nitric oxide in low birth
weight infants (109, 110). Research indicates that the sympathoadrenal system is also
affected in low birth weight infants (111). In a cohort of 449 male and female adults,
ranging in age from 46 to 54 years, resting pulse rate, blood pressure and birth weight
were recorded. Resting pulse decreased 76 beast per minute in those who weighed 2.5 kg
or less at birth and was correlated positively to systolic and diastolic blood pressure
providing a possible relationship between low birth weight, elevated sympathetic
nervous system activity and hypertension in adulthood (111). Galland et al. (112) found
similar results when examining heart rate variability between small and appropriate for
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gestational age infants. Though they found the autonomic component was lower in small
for gestational infants, the sympathetic component of heart rate variability was higher.
Other physiological mechanisms hypothesized to be caused due to an adverse
intrauterine environment include a failure to develop proper appetite regulation (94).
Therefore, undernutrition in utero results in a failure of the hypothalamic centers to
develop thus resulting in an inadequate control of food intake. Undernutrition during the
third trimester may result in decreased adipocyte differentiation and undernutrition
during the first or second trimester may result in increased adipocyte differentiation.
Therefore, undernutrition early in gestation would result in impaired regulation of food
intake and predispose to obesity in adolescence or adulthood.
Skeletal muscle is important for glucose disposal given that the majority of post
prandial glucose is taken up by the skeletal muscle (17). In utero determination of
primary muscle fibers is formed in humans during two phases starting between weeks 6
and 8 in gestation and completing by week 18. Research suggests that genetics
determines the number of primary fibers however; secondary fiber amount is affected by
environment (17). Maternal malnutrition has been shown to affect number of fetal fibers
(113, 114). Research indicates that reduced nutrient supply to the fetus can alter muscle
fiber number by reducing the total count. Therefore, given that muscle functions as a
large site for glucose uptake, reduced fibers could easily contribute to hyperglycemia
and insulin resistance.
Another important organ involved with metabolic control and hypothesized to be
affected by intrauterine growth restriction is the liver (17). In rat models, research (115)
has shown growth retarded rats have a decreased oxidative phosphorlyation and
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therefore less ATP generation, and this is further exacerbated by the fact that redox
states are uncoupled in the liver and therefore less ATP is generated per molecule of
glucose. Further research in rat models have found an upregulation in hepatic
gluconeogenic enzymes (116) therefore increasing glucose release from the liver and
contributing to insulin resistance. Maternal malnutrition has also been suggested to
program the offspring for increased hepatic fatty acid synthesis thus increasing hepatic
triglycerides (117). Increased hepatic triglycerides are thought to contribute to decreased
skeletal muscle insulin sensitivity therefore sparing glucose to use in support of growth
in utero for vital organs such as the brain.
The human hypothalamo-pituitary-adrenal (HPA) axis begins to develop early in
fetal life and further develops in the postnatal period (118, 119). Activation of the HPA
axis results in release of glucocorticoids, which is mainly cortisol in humans (120). This
is important because increased HPA activation and therefore cortisol release in humans
in related to increased risk of development of atherosclerosis, hypercholesteremia and
type 2 diabetes. Epidemiological research has indicated relationships between birth
weight, plasma cortisol and the development of hypertension and type 2 diabetes (121,
122). There are several maternal prenatal stressors that can affect the programming of
the HPA axis in the offspring including maternal stress, increased exposure to
glucocorticoids in utero and maternal malnutrition (119). It is not entirely understood
how prenatal stress affects development of the HPA axis in the offspring, though it is
thought stress causes changes in maternal cardiovascular and endocrine features. Stress
during pregnancy can increase the release of ACTH, beta-endorphin, glucocorticoids and
catecholamines though the placenta forms a structural and biochemical barrier to many
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of these factors (119). Even so, several will still cross and reach the developing fetus.
Furthermore, catecholamines can result in constriction of blood vessels therefore causing
fetal hypoxia which will stimulate the fetal HPA axis (119).
Even though several factors are thought to adversely affect HPA axis due to
prenatal stress, glucocorticoids are the primary candidate (119). During pregnancy,
glucocorticoids function to maintain normal development of the brain however
consistent sustained high levels of glucocorticoid exposure to the fetus can modify brain
structure and function (120). Furthermore, elevated glucocorticoid exposure during
gestation is thought to compromise development of the hippocampus causing a cascade
of events resulting in hippocampal deficit and extended HPA responses to stress and
elevated cortisol exposure (119).
Another target for fetal programming of adult disease is the adipocyte and
hormones secreted by the adipocyte. Leptin is a hormone secreted by the adipose tissue
and acts to signal as to the amount of energy stores, specifically fat mass (17). Leptin
binds at sites both centrally and peripherally to decrease food consumptions and increase
energy utilization. Similar to having high circulating concentration of insulin in adult
obesity, high amounts of leptin are also present during adult obesity and it is thought
leptin resistance plays a role in obesity development (17). Hypotheses suggest high
circulating levels of leptin cause an uncouple of the action of leptin at the hypothalamus
therefore disturbing the signals that decrease appetite (123). There are leptin receptors
located on the pancreatic beta cells and leptin will inhibit insulin secretion and stimulate
adipogenesis of adipose tissue (124).
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Due to the function of leptin, it is hypothesized that leptin plays a role in early
programming of human obesity (17). A positive relationship exists between cord leptin
at delivery and birth weight and body fat of the infant. In pregnancies complicated by
altered metabolic control, the infant is born hyperinsulinemic and hyperglycemic and
cord levels of leptin are positively related to infant body fat (125). Research shows low
birth weight is associated to high levels of plasma leptin, even when controlling for
degree of adult obesity (126).
Disease Development Related to High Birth Weight
Many studies have established a link between low birth weight and adult disease
development (35, 97, 98, 103), however only 5% of infants in the United States are born
with a low birth weight (38). We are instead faced with conditions of over abundance of
nutrition and an obesity crisis. The prevalence of obesity in women aged 20-39 during
reproductive age is 30% (1) therefore many females enter into pregnancy in an obese
state putting themselves at risk for metabolic complications and poor pregnancy
outcomes (36, 37) . Furthermore, recent research has shown over the last 25 years, the
mean weight of females at their first prenatal visit has increased 20% as well as the
percent of women with a BMI greater than 29 kg/m2 (39). These increases were related
to increased risk for these women of gestational diabetes and delivering a large for
gestational age infant.
Just as undernutrition can have a detrimental impact on later health, research
suggest overnutrition during prenatal and perinatal periods can have similar detrimental
health effects on the infant (45-50, 127, 128). Overnutrition before and during pregnancy
is associated with delivering large for gestational babies (>4000 grams). A high birth
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weight due to over-nutrition during gestation is shown to increase the chance of obesity
development, type 2 diabetes and the metabolic syndrome later in life (13).
Overnutrition late in gestation may change adipose tissue differentiation and promote
obesity in adolescence or adulthood (94).
Though many studies have examined the relationship between under nutrition
and adult disease, few studies have examined over nutrition and the impact of fetal
health in adulthood. Research has shown maternal health is related to health outcomes in
the infant. In an Italian population, it was shown that hypercholesterolemia was related
to increased rates of fatty streaks of the fetus in a post mortem study (42, 43). Evidence
from population studies of Pima Indies shows a high likelihood of maternal diabetes
being passed to the offspring (44).
The exact physiological mechanisms underlying changes to over nutrition during
pregnancy are not as straightforward as under nutrition. Much of the information that has
been gathered has been done in animal models of either rat, sheep or pig. There are
several systems that are suggested to be affected by maternal over nutrition leading to
offspring development of adult disease: appetite regulating network (45-50),
cardiovascular system (42, 51, 52) and insulin sensitivity (51, 53, 54). Each one will be
reviewed in the paragraphs below.
In rodent models exploring effects of development of appetite control, research
shows specific areas of the brain to be affected (55, 56). The hypothalamic neural
network integrates signals regarding energy status to send feedback to regulate food
intake and energy expenditure (47). Appetite regulating neuropeptides are located in the
arcuate nucleus of the hypothalamus and have projection extending to other hypothamic
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nuclei that control the release of appetite suppressing and stimulating regulators.
Appetite stimulators include neuropeptide Y and agouti-related peptide while the
appetite suppressors are pro-opiomelanocortin derived neuropeptide alpha melanocortin
stimulating hormone and cocaine and amphetamine regulated transcript (47).
Increased exposure of nutrition caused by over nutrition of the mother causes
changes in the morphology of the areas of the brain responsible for control of appetite
(46, 55, 56). Research has shown increases in the area of neuronal nuclei and cytoplasm
within the paraventricular nucleus and ventromedical nucleus and decreases in the area
of neuronal cytoplasm in the arcuate nucleus (56). These changes occur in concert with
decreased sensitivity to leptin and insulin as well as to central hypothalamic
neuropeptides. Therefore, in cases of over nutrition, the satiety signals are not
recognized (46, 55, 56).
The pancreas and muscle are other organ systems suggested to be affected by
maternal over nutrition (53, 54). Taylor et al. examined the impact of a maternal high fat
diet derived from saturated fat on the metabolic outcomes of the offspring in a rat model
(53). They found offspring of high fat mothers were more insulin resistant, had greater
circulating levels of leptin and higher levels of resting glucose and insulin than controls.
This group also showed impaired pancreatic beta cell insulin secretion and structural
changes in the pancreas. Furthermore, the high fat offspring had higher levels of
triglycerides and reduced levels of HDL cholesterol.
The cardiovascular system which regulates blood pressure is also suggested to be
affected by in utero exposure to maternal over nutrition (52, 57). Research has shown an
inability of female offspring of over fed mothers to regulate blood pressure due to
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altered baroreceptor sensitivity (57). Ghosh et al. (52) studied vascular function of
offspring from mothers that were fed a high saturated fat containing diet. Endothelial
dependent vasodilation was blunted and there was a reduction in endothelial derived
hyperpolarizing factor, involved with relaxation of the arteries, in offspring of the high
saturated fat fed mothers. Furthermore, the fatty acid of the aorta was abnormal and
elevated levels of triglycerides and reduced levels of HDL were detected (52).
There are many similarities of affects between offspring exposed to under
nutrition and over nutrition. In regards to over nutrition, growing evidence is suggesting
that saturated fat is most detrimental to development of offspring. More research is
needed to clarify relationships.
Birth Weight Related to Later Body Mass Index in Adults
Birth weight is frequently used as an indicator of conditions experienced by the
infant during gestation. The prenatal period has been indicated as a critical time for
programming of later obesity development as suggested by the critical period hypothesis
(13). This hypothesis proposes the intrauterine conditions the infant is exposed to may
encourage obesity development throughout life. Thus, a higher birth weight is indicative
of a positive intrauterine environment due to overnutrition whereas a low birth weight
indicates a negative intrauterine environment due to undernutrition (129). Exposure to
either a positive or negative intrauterine environment can adversely impact the health of
the infant.
Several research studies have been performed to examine the relationship
between birth weight and subsequent BMI in adulthood (19, 21, 22, 130-139). Many of
these are large scale cohort studies using census or registry data to compare birth weight
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to weight in adulthood. In one such study, Rasmussen and Johansson (21) used the
Swedish Medical Birth Registry to identify 165,109 singleton male births between 1973
to 1976 and obtained height and weight data at 18 years from the Military Service
Conscription Registry for the years 1990 to 1996. A direct relationship was found
between birth weight for gestational age and BMI at age 18 years. Using multivariate
analysis, a high birth weight was found to be a risk factor for risk of overweight (BMI >
25 kg/m2) after controlling for living area, mother’s age, educational level and number of
births. Using birth weight between the 25th and 50th percentile as the reference category,
those with a birth weight between the 95th and 99th percentile had an odds ratio for
overweight of 1.50 while birth weight above the 99th percentile had an odds ratio for
overweight of 1.67. Similar odds ratios were found for severe overweight (21).
Sorensen et al. (137) linked the Danish medical birth registry to information
obtained by the Danish draft board to obtain birth weight, height and weight data on
4300 males. The prevalence of obesity was calculated based on weight and length at
birth. Results found a continual increase in BMI with increasing birth weight with 3.5%
obese at birth weight 2500 grams to 11.4% obese at birth weight 4501 grams. Using
multivariate analysis and controlling for mother’s age, marital status and occupation,
birth weight was found to be related to adult BMI (137). Analogous methods were used
to study the impact of birth weight in Norway on subsequent BMI in adulthood in
348,706 males only (139). The Medical Birth Registry of Norway was used to collect
birth weight while follow up height and weight were collected through registration with
the military draft. A positive association was found between birth weight and adult BMI
for birth weights >2500 grams.
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Using similar methods to collect data, Tuvemo et al. (130) used the Swedish birth
register and the Swedish conscript register to determine if a relationship existed between
birth weight and adult BMI in 39,901 males. Logistic regression was used to identify the
risk of being overweight in young adulthood and odds ratio estimated relative risk. An
increase in adult BMI was seen with a birth weight of <2500 grams relating to a BMI of
21.93 kg/m2 and a birth weight of 4500 grams relating to a BMI of 23.02 kg/m2.
Compared to those with a low ponderal index (birth weight in grams/length in cm3), men
with a high ponderal index had an odds ratio for obesity of 1.8 (130).
A study (132) performed using Israeli draft medical examinees was the first to
include data on females, although the female population comprised only 39%. Data was
used on 33,413 infants born between 1964 and 1971 and followed up at 17 years. A
positive association was found in males and females between overweight (BMI 90th
percentile) and severe overweight (BMI 95th percentile) to a birth weight >3000 grams.
This association was found when controlling for ethnic origin, parental education level,
birth order or area of residence. Additionally, an odds ratio for overweight of 2.16 in
males and 2.95 in females with a birth weight 4500 grams compared to a birth weight
of 3000-3499 grams. No difference was found in BMI between those with a low birth
weight (<2500 grams) to those in the reference category (3000-3499 grams) (132).
Two large scales studies have provided information regarding the relationship
between birth weight and BMI using data from the United States (19, 22). Information
was obtained on 51,289 men using data from the Health Professional Follow-up Study
and 71,100 women aged 30-55 years and 92,940 women aged 25-42 years using data
from the Nurses’ Health Study I and II. In the Health Professional Follow-up Study, a
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birth weight of 7.0-8.4 lb (3.2-3.8 kg) was used as the reference category and odds ratios
of being in the highest versus the lowest quintile of adult BMI were calculated (19).
Those with a birth weight of 8.5-9.9 lb (3.86-4.5 kg) had an odds ratio of 1.5 of being in
the highest quintile of adult BMI. In men with a birth weight of over 10 lb (>4.5 kg), the
odds ratio of the being in the highest versus lowest quintile of adult BMI was 2.08.
However, for men with a birth weight of 5.5-6.9 lb (2.5-3.1 kg), the odds ratio declined
to 0.75 (19).
Similar analyses were completed on the data in women using a birth weight of
7.0-8.4 lb (3.2-3.8 kg) as the reference category (22). In those aged 30-55 years with a
birth weight 8.6 to 9.9 lbs (3.86-4.5 kg), the odds ratio of being in the highest versus
lowest BMI quintile was 1.19 and those with a birth weight >10 lb (4.5 kg) had an odds
ratio 1.62. Interestingly, a U shape relationship was found between mean BMI and birth
weight category where a greater BMI was seen in birth weights below 5 lb and above 7
lb. A J relationship between birth weight and BMI was found in a group of 297 women
in East Hertfordshire where an increase in BMI was found with increasing birth weight
(P=0.05) (133).
Parsons et al. (27) studied 10,683 male and female infants born in 1958 from
Scotland, England and Wales and found a J shape between birth weight and later BMI.
Initial birth weight was obtained with follow up data collected at age 7, 11, 16, 23 and
33 years. The relationship between birth weight and BMI was a J shape in both men and
women although a linear relationship was found at ages 7, 11 and 16. In males, BMI
increased with increasing birth weight in the highest birth weights only (27).
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Phillips and Young (136) studied 1750 males and females born between 1920
and 1930 and found with increasing birth weight, BMI in adulthood increased as well.
The same results were found in a group of young Swedish women born between 1973
and 1978 (134). A study by Khan et al. (135) also found a linear association between
birth weight and BMI (P=0.0004) at age 17-22 years in males who had applied for
military service. A final study also examined males only born between 1920 and 1924 in
Sweden (138). A weak correlation was found between birth weight and adult BMI at age
50 (r=0.10; P<0.001).
Birth Weight Related to Later Body Mass Index in Children
Several studies have assessed birth weight as a predictor of overweight and risk
for overweight in childhood as well (58, 140-146). The importance of obesity
development in childhood is highlighted by the statistic that show a child who is obese
as an adolescent has an 80% chance of carrying the obesity into adulthood (147).
Birth certificates of participants of the Women, Infant and Children special
supplemental food program for low income families in Tennessee were used to obtain
weight of infant (140). Birth weight was stratified and compared to weight of child at 3
to 5 years of age. Higher birth weight was directly related to a greater risk of obesity
development using a weight for height z score 2. The prevalence of obesity in 36-41
month olds with a birth weight of 1000-1499 grams was 1.0% but jumped to 8.7% for a
birth weight of 4500-4999 grams (140).
Fisch et al. (141) prospectively collected data in 1,786 Minnesota children relate
birth weight to obesity at ages 4 and 7. Birth weight was classified as extremely obese
using a body weight score 95th percentile. Obesity at birth was directly related to weight
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for height >70th percentile at both 4 and 7 years old. Extremely lean children (0 to 5th
percentile) and extremely obese children (95th percentile) at 4 years tended to remain in
their respective classification at 7 years (141). A second prospective longitudinal study
in Australia started with an interview of the mother pre-delivery and then followed
mother and child for visits immediately after deliver, at 6 months and at 5 years (58).
Complete data was obtained on 4,602 subjects and moderate obesity was defined as a
BMI between 85th and 94th percentile while severe obesity was defined as BMI >94th
percentile. Birth weight was an independent predictor of both moderate and severe
obesity and the odds ratio of severe obesity was 1.8 for a birth weight 95th percentile
(58).
Data from the Study of Children’s Activity and Nutrition Project (SCAN) were
used to examine the relationship between birth weight and child’s BMI at the age of 4
(n=331) (146). This study focuses on determinants of body fatness in Anglo-Americans
and Mexican-Americans. Pearson correlations were significant between birth weight and
child’s BMI (r=0.28; P<0.001) and sum of skinfolds (r=0.16; P<0.01) (146). Research of
1,901 boys and girls aged 7 to 14 years in Germany using cross sectional surveys in
1975, 1985 and 1995 found an association between birth weight and weight in
adolescence (142). Using regression and controlling for socio demographic variables, a
significant relationship was found between risk of overweight (BMI >90th percentile)
and weight at birth in boys (P=0.04) and girls (P=0.035) (142).
Other research studies have been completed but data were collected in developed
and often impoverished countries (143-145). In one report, data was obtained from a 25
year longitudinal study in an impoverished Latino village in Guatemala from 1969 to
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1977 therefore the applicability to other populations may be limited (143). In 1988 to
1989 a follow up was completed and data was obtained from 1,373 subjects. A positive
relationship between weight at 15 days and BMI up to 4 years in girls (r=0.27; P<0.01)
and up to 5 years (r=0.16; P<0.0001) in boys. A second study (144) examined 748
preschool boys and 574 preschool girls in China age 0.1 to 6.9 years. High birth weight
4000 grams was identified as a major risk factor for obesity development (P<0.05).
Bavdekar et al. studied 8 year old Indian children who had participated in an earlier
study at the age of 4 years (145). Children with a higher birth weight were heavier at 8
years (P<0.001) however, a J shaped relationship was found between birth weight and
BMI. At a birth weight of <2.0 kg, this corresponded to a BMI of 13.5 kg/m2. BMI then
declined for those at a birth weight of 2.25 kg and 2.5 kg; at a birth weight of 2.75,
BMI climbed back up to 13.5 kg/m2 and continued to increase linearly (P<0.001) (145).
Though the above studies indicate a relationship between birth weight and BMI,
a number of studies have found no relationship between these two variables (148-153).
Research and study populations in adults finding no relationship include 541 Mexican-
American adults (148), 217 middle-aged adults from the United Kingdom (149), 331
postmenopausal Americans (150) and 620 Danish males and females (151). In children,
no relationship between birth weight and BMI was found in 7 to 12 year old Americans
(n=237) (152) and 9 to 10 year old Italian children (n=110) (153). Possible reasons for
discordant findings between studies may be that these studies did not control for
sociodemographic factors in analysis, which represents an important determinant of later
obesity. Some of these study populations represent low socioeconomic status population
and more often low birth weight is common in their children. Research has shown that
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obesity decreases with increasing socioeconomic status and thus represents an important
confounder factor (154). All of the above mentioned research had study populations
below 1,000 therefore they may not have been statistically powered to detect differences
that truly existed.
Maternal Obesity and Obesity Development in Offspring
Research has indicated a positive relationship between obesity of the mother and
obesity development in the offspring (30, 58, 155-159). Therefore, this indicates obesity
in the offspring may be caused by genetics, an adverse intrauterine environment or
effects of the postnatal environment such as breastfeeding. In addition to maternal
obesity, parental obesity is also related to obesity development in the offspring (58, 157,
158). Thus, this indicates a genetic cause for obesity development in the offspring. A
relationship also existed between maternal BMI and birth weight (160, 161).
Data from the Child Health and Development Studies and in the Adolescent
Study have provided evidence of the relationship between maternal obesity and obesity
development of the offspring (162). Collection of data commenced in 1959 and followed
mothers during pregnancy in the San Francisco East Bay area of California. This data
was analyzed on 1,993 subjects who had measurements assessed at birth and again at 15,
16 or 17 years. Infants were categorized based on birth weight as small for gestational
age (<10th percentile for birth weight), appropriate for gestational age (10th to 90th
percentile for birth weight) and large for gestational age (>90th percentile for birth
weight). Age specific percentiles of BMI were used to classify mothers. Across each
birth weight category there were significant differences in BMI between high maternal
BMI and low maternal BMI. High maternal BMI was associated high adolescent BMI.
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When the mother was classified with a high BMI, the risk of the obesity development in
adolescents was two times those infants who were small or appropriate for gestational
age. Additionally, those who were large for gestational age with a mother who had a
high BMI had a 5.7 times greater risk of adolescent obesity than those who had lean
mothers. Using multiple regression analysis, maternal and parental BMI predicted
adolescent obesity, however birth weight was not related (162).
Another large scale longitudinal study has found a relationship between maternal
obesity and offspring obesity development at age 7 years (30). The Avon Longitudinal
Study of Parents and Children followed children born between 1991 and 1992 in the
United Kingdom. The subjects (n=5,493) were brought in for regular exams and obesity
was defined as a BMI 95th percentile. Pre-gravid BMI of mother was self reported and
was classified as either <30 kg/m2 or >30 kg/m2. Adjusted odds ratio for obesity at age 7
years was 4.25 when the mother’s BMI was greater than 30 kg/m2. The odds ratio was
adjusted for maternal education, energy intake at 3 years and gender (30).
Li et al. (159) studied 2,636 subjects participating in the 1996 National
Longitudinal Survey of Youth, Child and Young Adults in the United States. Height and
weight of the children aged 2 to 14 years was measured by trained personnel and
overweight was defined as BMI 95th percentile using the Centers for Disease Control
growth charts. Maternal pre-gravid BMI was recorded by self report of the mother and
categorized as overweight (25 kg/m2  BMI <30 kg/m2) and obese (30 kg/m2). A linear
trend between maternal pre-gravid BMI and increased risk of overweight in childhood
was found (P<0.001). Children were at a 4 times greater risk of overweight in
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adolescence if their mothers were obese compared to those children whose mothers had
a normal BMI (159).
Using data from the National Collaborative Perinatal Project and the Philadelphia
Blood Pressure Project, risk for increased adiposity in adulthood in African Americans
was assessed (163). A total of 447 subjects participated who had a recorded birth weight
and follow up data at age 18-23 years. At follow up, sum of 2 skinfold thickness were
assessed on the offspring. When subjects were enrolled in the study, maternal pre-
pregnancy weight was recorded by self report and maternal obesity was defined as BMI
30 kg/m2. Using multiple logistic regression, three factors were related to increased
adiposity; maternal pre-gravid BMI, female gender and first born status. An odds ratio of
1.15 was found for each kg/m2 increment increase in maternal pre-pregnancy BMI
(P=0.001) (163).
Data from the 1958 British birth cohort indicated a relationship between maternal
BMI and offspring adiposity (27). A J shape relationship was found however after
adjusting for self report of mother’s pre-pregnancy weight, this relationship disappeared.
The Nurses’ Health Study was also used to examine this relationship with 71,100
participants (22). Data indicated a relationship between maternal BMI and obesity in
adulthood however maternal body weight was assessed by identification of a closely
resembling image of their mother’s body shape at age 50 years.
Other research has found a relationship between birth weight and future obesity
in the offspring however independent of pre-gravid BMI (164-166). Duran-Tauleria et
al. (164) performed a cross sectional analysis consisting of 8,374 children who had
participated in an earlier study providing birth weight and parental BMI. Researchers
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measured weight and skinfold thickness in the children aged 5 to 11 years. Multivariate
analysis found, independent of parental or maternal BMI, age and gender adjusted
weight for height scores significantly related. Further research (165) in 1,363 children
from Italy found associations between risk of obesity and birth weight (P<0.01) and
parental or maternal BMI (P<0.001). However, using multiple logistic regression, the
association between obesity and birth weight remained independent of maternal or
parental BMI. Gallaher et al. (166) conducted a medical review of 261 preschool
children from the Mescalero Apache tribe. Children with an obese mother were two
times more likely to be obese than those with non obese mothers. Similarly, children
with a high birth weight (>4000 grams) were three times more likely to be obese
compared to a birth weight of 2000 to 2999 grams. Both of these results were after
adjusting for age, gender and maternal obesity.
Explanations for the discrepancies in results may lie in the fact that the effect of
birth weight on weight for height diminishes with age (164). Additionally, the findings
may be an artifact reflecting the accuracy of the assessment of birth weight and maternal
BMI. In nearly all studies, an accurate measure was obtained for birth weight either
through medical records or by the investigator however, maternal BMI was usually self
reported by the mother. This could result in the true relationship between obesity
development in the offspring and maternal BMI being underestimated.
Relationship of Maternal Pre-Gravid BMI to Offspring Body Composition
Few studies have attempted to assess infant body composition in relation to
maternal factors (59, 167). Furthermore, special populations such as infants could
potentially violate the underlying assumptions of the multi-component models therefore;
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the accuracy of the technique depends on the model and the associated assumptions.
When assessing body composition in infants, special consideration must be taken into
account when selecting a technique and caution must be used when examining the
results.
Assessment of infant body composition is often not feasible and routinely BMI
or the ponderal index is used to quantify infant risk of overweight. Of the studies that
have examined infant body composition in relation to maternal factors, the impact of
diabetes during pregnancy is often compared to those without diabetes. Catalano et al.,
(167) assessed infant body composition using skinfold measurements from 195 mothers
who had gestational diabetes and compared this to body composition from 220 infants
born to mothers with normal glucose tolerance. No differences between groups were
found for birth weight or fat-free mass however infants from mothers with gestational
diabetes had greater skinfold measurements and fat mass. Furthermore, fasting glucose
levels were had the greatest correlation with infant body fat (167).
One study has assessed infant body fat and compared this by pre-gravid BMI of
the mother by dividing into this two categories: normal (<25 kg/m2) and
overweight/obese (25 kg/m2). Sewell et al. (59) compared body composition of infants
using TOBEC from mothers who were overweight/obese (25 kg/m2) and mothers who
were normal (<25 kg/m2). All subjects were tested and classified as normal glucose
tolerant based on results of an oral glucose tolerance test. Those with positive screen for
gestational diabetes were excluded from analysis. Within 72 hours of delivery, infant
body composition was tested (59).
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A total of 76 (34 female and 42 male) infants were from overweight/obese
mothers and 144 (67 female and 77 male) were from normal pregnancies (59). Infants
from mothers who were overweight/obese had greater body fat (11.6 %fat versus 9.7
%fat; P=0.03) and fat mass (420 g versus 380 g; P=0.01). Birth weight approached
significance (P=0.051) (3284 g versus 3436 g) with overweight/obese women infants
weighing more at birth. Linear regression was used to assess the impact of weight gain
during pregnancy on infant body composition measures. In the normal group, fat-free
mass was associated with weight gain while in the overweight/obese group, infant body
fat was associated to weight gain during pregnancy (59). Multiple stepwise regression
was used to examine which factors contributed to the prediction of infant body
composition measures. In normal mothers, gestational age and fetal gender explained
20% of infant body fat while fat-free mass was explained by gestational age and
maternal weight gain. In the overweight/obese group, infant body fat was explained by
weight gain, gestational diabetes screen and gestational age with gestational age and
weight gain contributing the most. Furthermore, in the overweight/obese group fat-free
mass was explained by gestational age, gender and nulliparity with gestational age
contributing the most (59).
Sewell et al. found the differences between groups were attributed to increases in
fat mass and not fat-free mass. This is the first study to compare pre-gravid BMI of the
mother to infant body composition. Other studies (168) have compared pre-gravid BMI
to infant birth weight and found a positive relationship, but they failed to assess which
component of birth weight (fat mass versus fat-free mass) was responsible for the
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difference. Thus, women who are overweight/obese when compared to normal women,
had infants with greater body fat and fat mass (59).
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CHAPTER III
METHODS
The purpose of this study was to compare infant body weight and composition
from mothers who were categorized as normal (<25 kg/m2) or overweight/obese (25
kg/m2) pre-gravid body mass index (BMI).
Subjects
The study sample consisted of 72 full-term infants and their mothers recruited
from Oklahoma City, Oklahoma and surrounding areas, who were healthy full-term
infants <35 days old. Eligibility for participation included the following criteria at
baseline: 1) healthy male or female full-term infant with a gestational age of >37 weeks
and 42 weeks and 2) mothers at the time of delivery between the ages of 18 to 45 years.
Exclusion criteria for the study included: 1) infants with a prolonged medical stay
defined as >3 days, 2) tobacco use during pregnancy, 3) excess alcohol consumption
during pregnancy defined as >1 drink a week, 4) infants with presumed or known
chromosomal or severe congenital abnormalities, and 5) infants from mothers with type
1, type 2 or gestational diabetes.
Two groups of subjects were recruited: 1) 33 infants born to mothers with a pre-
gravid BMI of <25 kg/m2 and 2) 39 infants born to mothers with a pre-gravid BMI of
25 kg/m2.
Study Design
This research study used a cross-sectional study design. Subjects were required
to participate in one visit, during the visit, body weight, length and body composition
were assessed in the infant. In addition, mother’s height and weight were measured.
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Procedures
Participants were recruited by a mass email sent to the University of Oklahoma
Health Sciences Center, newspapers advertisements, announcements in birthing classes,
and flyers placed at various pediatric clinics throughout the greater Oklahoma City area.
All testing occurred in Children’s Hospital in Oklahoma City. The testing procedure
began with an orientation where the entire testing procedure was explained along with
all risks and benefits of participation. Once all questions were answered, an informed
consent and HIPAA form was signed and copies of the signed documents were given to
the participants. Air-displacement plethysmography (i.e. Pea Pod®) was used to assess
body volume of the infant while naked in the Pea Pod®. This study was approved by the
Institutional Review Board for Human Participants at the University of Oklahoma
Health Sciences.
Body Weight
Body weight of the infant was obtained using the Pea Pod® scale. To assess body
weight, the infant’s clothing and diaper was removed. The infant was placed naked on
the scale and a body weight was obtained to the nearest 0.01 kg. Body weight of the
mother was obtained with shoes removed and in minimal clothing. A physician’s
balance beam scale was used to measure body weight in kilograms to the nearest 0.1 kg.
Height
Height of the mother was obtained using a stadiometer (Accu-Hite Wall
Stadiometer, Seca Corp., Hanover, MD). She removed her shoes, was centered on the
stadiometer and placed her hands on hips. After an inhalation, height was measured to
the nearest 0.1 centimeter.
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Length
Crown to heel length of the infant was assessed using a length board. The infant
was placed on their back with their head against the immovable piece of the stadiometer
and their legs placed toward the adjustable end of the stadiometer. Next the infant was
stretched out so their head remains stable but their legs are extended. At the point where
their legs are extended, the adjustable portion of the stadiometer was moved so that it is
flat against their outstretched feet. A reading was taken and recorded to the nearest 0.1
centimeter.
Air Displacement Plethysmography by the Pea Pod®
The Pea Pod® Body Composition System (Life Measurement Instruments,
Concord, CA) was used to assess body volume and used to calculate body density. The
Pea Pod® was calibrated before each test or once daily during testing days when multiple
tests were performed. A calibration cylinder with a known volume was used to calibrate
the chamber and a 5000 gram weight was used to calibrate the scale.
When testing takes place, the infants were naked, with all clothing and diaper
removed. Weight of the infant was obtained prior to start of the measurement. After
body weight was measured, the infant was placed inside the Pea Pod® and a body
volume measurement was completed. Assessment of the body volume lasted
approximately 2 minutes and once body volume was obtained, the test was complete.
Body density was then converted to percentage of fat (%fat) using gender specific
equations by Foman (169).
The concept of air displacement plethysmography (ADP) is not new, but only
within the last 10 years has it been made commercially available for body composition
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testing (60). The first product utilizing ADP was a version used to test adolescents and
adults. Recently, an infant version has been made available (75) and holds promise to
provide a method for a fast and accurate method to assess body composition in infants.
ADP involves assessment of body density by measurement of body volume (75).
A two-compartment approach to body composition is then applied in which body density
is used to calculate percent body fat (% fat), fat mass and fat-free mass (61). Body
density equals body volume divided by body weight. Assessing body weight in air is
achieved by using a scale.
Application of basic gas laws allow for body composition assessed by ADP
based on the relationship between pressure and volume (60, 75). Boyle’s law states at
constant (isothermal) temperature, pressure and volume are inversely related:
P1/P2=V2/V1
where P1 and V1 are pressure and volume at an initial state and P2 and V2 are pressure
and volume at a final state. Air inside the test chamber is however, under adiabatic
conditions (occurring with loss of heat). Therefore the air inside the chamber does not
remain constant as volume changes and as molecules gain or lose kinetic energy. Thus,
Poisson’s Law describes the relationship used by ADP under adiabatic conditions (60,
75) and is described using the following equation:
P1/P2 = (V2/V1)
where  represents a constant (1.4) for air. Equations 1 and 2, illustrate that volume
changes result in different pressure changes for air under adiabatic and isothermal
conditions. Air under isothermal conditions is more easily compressed than air under
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adiabatic conditions and therefore air under adiabatic conditions will be overestimate by
40% (60).
The Pea Pod® is mounted entirely on a cart to allow ease of movement to testing
locations. The testing chamber, reference chamber, calibration volume, electronics, and
scale are all based on the cart. Between the test and reference chamber is a volume
perturbing diaphragm and a pneumatic calibration valve connects the test and calibration
volume. The scale is mounted on the surface of the unit to assess weight using a strain
gauge and the scale has a capacity of 12 kg (75).
During testing, oscillations in the diaphragm create sinusoidal volume
perturbations in the test and reference chamber (75). The volume perturbations operate at
a magnitude and frequency of 35 mL and 6 Hz, respectively. Changes in pressure
resulting from volume perturbations are below ±0.5 cm H20 and maintained low for
comfort. For a known volume in the reference chamber under adiabatic conditions,
changes in the test chamber are a linear function of the ratio of the pressure perturbations
between the test and reference chambers (75). Due to the compressible nature of
isothermal air, these volumes must be corrected. Therefore, during testing sources of
isothermal air, such as air close to the skin, in the hair and air in the lungs must be taken
into account. Failing to account for isothermal air in the testing chamber would result in
a 40% overestimation of volume behaving isothermally when adiabatic conditions are
assumed. To correct volume estimates, the surface area artifact (SAA) was calculated
(75). During volume measurements, the Pea Pod computer software calculated body
surface area (BSA) and multiplied it by a constant (k) to obtain SAA using the following
equations:
47
BSA (cm2) = 178.27 * length (cm)0.5 * weight (kg)0.4838
SAA (L) = k(L/cm2) * BSA (cm2)
Due to isothermal air in the lungs, where adiabatic conditions are assumed, air in lungs is
overestimated by 40% resulting in the body volume of the subject being underestimated
by 40% of the subject’s thoracic gas volume (TGV) (75). To correct this, TGV is
estimated and 40% of the estimated TGV is added back to the measured value of the
subject’s body volume. Direct assessment of TGV is not feasible in infants so it is
predicted.
TGV= Functional residual capacity (FRC) + ½ Tidal volume (TV)
FRC can be assessed by helium dilution or plethysmographic assessment. However
helium dilution results in lower values of FRC due to trapped air in the lungs
undetectable by helium dilution (170). The Pea Pod® uses a plethysmographis derived
equation to calculate FRC shown below (171):
FRC (mL) = 2.36 * length (cm)0.75 * weight (kg)0.63
TV values depend on age and mass of the infant and are equal to 7 ml/kg at birth, 9
ml/kg at 3 months, 9.3 ml/kg at 6 months and 9.5 mL/kg at 12 months (172).
TGV is then calculated based on the following formula:
TGV = FRC + ½ TV
These values are used to calculate raw body volume (BVraw) and body volume (BV):
BV (L) = BVraw – SAA (L) + 40% TGV (L)
The remaining factor needed to calculate body density and %fat are body mass of the
subject (Mb):
Mb/Db = Mf/Df + Mfm/Dfm
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%fat = (Mf/Mb) * 100%
where Mf is fat mass, Df is fat density, Mffm is fat-free mass (equal to Mb – Mf) and
Dffm is density of fat-free mass. A known value for Df equal to 0.9007 g/mL (61) is
used in the equation. However, age and sex specific Dffm values must be used and are
presented elsewhere (169).
Prior to the start of testing, volume calibration was completed using a phantom of
known volume and every two weeks or when the device has been moved, the scale is
calibrated using an NIST-traceable calibration weight (5000 grams) (75). Once the
device is calibrated, the test procedure begins with a simultaneous body mass
measurement and an automated volume calibration. While the test chamber is empty,
changes in pressure are assessed with the calibration open and closed. A two point
calibration is completed with the closing and opening of the calibration valves. This
procedure lasts less than a minute and upon completion the test chamber is ready for
placement of the infant inside the tray for body volume assessment (75).
The tray and the infant were pushed inside the device and the door is shut to start
the assessment. Within the first 15 seconds of the test, air outside the test chamber is
allowed to mix with air inside the test chamber avoiding temperature dependent
deformations in the walls of the test chamber due to the generation of heat by the infant
(75). Over the next 25 seconds, pressure changes occurring between the test and
reference chamber are recorded. Two volume measurements are obtained and if they are
within 5 mL of each other, then the mean is used to determine %fat. If the volume
measurement fails, a third is taken and the mean of the two within agreement are used to
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calculate %fat. When three measurements are not in agreement, then the test must be
repeated (75).
Statistical Analysis
Descriptive statistics (means and standard deviations) were calculated for all
outcome variables (birth weight, %fat, total fat mass and fat-free mass) within both of
the two groups according to mother’s pre-gravid BMI status. The two groups were
compared to determine if any differences existed between them. For interval data,
independent t-tests were used and for nominal data a chi-square test was completed.
To determine whether birth weight and body composition, adjusted for infant age
at visit, differed based on pre-gravid BMI (2 levels: normal and overweight/obese),
analysis of covariance (ANCOVA) was performed. Stepwise multiple linear regression
analysis determined which maternal factors were related to infant outcome variables.
The dependent variables used in the model were: neonate birth weight, %fat, fat mass
and fat-free mass; independent variables were gestational age, infant age at testing,
maternal pre-gravid body weight, BMI, maximum body weight, weight gain, gender and
socioeconomic status. The alpha level was set at P  0.05.
Power/Sample Size Considerations
Cohen’s d (173) was calculated using the following formula:
where ‘d’ is the expected mean difference between any two groups and ‘SD’ is the
standard deviation for individual measurements. Once ‘d’ was calculated, a power table
was used to determine the estimated sample size. The mean difference in infant birth
weight between overweight/obese mothers and normal weight mothers was 2.0 ± 2.5
d=M1-M2
SD1+SD2 /2
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%fat (59, 174). A significance level of 0.05 and 80% statistical power were used to
estimate sample size as shown in Table 2.
Table 2. Sample size determination.
d sd N(estimated sample size)Groups
Percent Body Fat (%fat)
Overweight/obese vs. Normal 2.0 2.5 26
(d: mean difference; sd: standard deviation)
Since the calculated sample size per group was 26 subjects, we anticipated a
possible non-compliance rate of 25%, we considered a total sample size of 66 (33
subjects per group) to be adequate.
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Objective: The purpose of this study was to compare body weight and composition
(%fat, fat mass, and fat-free mass) in neonates born to mothers with a normal pre-gravid
body mass index (BMI; <25 kg/m2) versus neonates born to mothers with an
overweight/obese pre-gravid BMI (25 kg/m2).
Study Design: Seventy-two neonates (33 from normal mothers and 39 from
overweight/obese mothers) of singleton pregnancies with normal glucose tolerance had
their body weight and body composition assessed by air-displacement plethysmography.
Results: After controlling for neonate age at time of testing, significant differences were
found between groups for %fat (12.5 ± 4.2 % vs. 13.6 ± 4.3 %; P0.0001), fat mass
(414.1 ± 264.2 g vs. 448.3 ± 262.2 g; P0.05) and fat-free mass (3310.5 ± 344.6 g vs.
3162.2 ± 343.4 g; P0.05), with no significant differences between birth length (50.7 ±
2.6 cm vs. 49.6 ± 2.6 cm; P=0.08) or birth weight (3433.0 ± 396.3 g vs. 3368.0 ± 399.6
g; P = 0.44).
Conclusions: Neonates born to mothers who have a normal BMI have significantly less
total and relative fat, and more fat-free mass than neonates born to overweight/obese
mothers. Though preliminary, these data suggest that the antecedents of future disease
risk (e.g. cardiovascular disease, diabetes, and obesity) occur early in life.
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Background
Maternal prenatal obesity has increased significantly over the past 15 years with
maternal body weight at the first prenatal visit increasing by 20% (39, 175). At the same
time, neonate birth weight in North America and Europe has increased, with birth weight
>90th percentile and >4000 grams increasing the most (40, 41). A body of work has
emerged to show a positive relationship between maternal body mass index (BMI) and
the birth weight of their off-spring (28, 176-178), with newborns at a birth weight 90th
percentile possessing the greatest risk of obesity later in adulthood (21, 130, 137, 139).
Intrauterine life is a crucial period with epidemiologic data indicating that a sub-
optimal intrauterine environment affects future chronic diseases (179, 180). Barker has
proposed that prenatal factors that alter or impede fetal growth in utero may have long-
term ramifications and may be in part responsible for obesity (181), diabetes (182),
hypertension (183), insulin resistance (184), cardiovascular (179), and heart disease (97,
179, 185-187). Barker coined the hypothesis “the fetal origin hypothesis”, which refers
to the induction, deletion, or impairment of fetal growth by an early event in utero that
alters fetal tissue on a molecular or physiological level (15, 16).
The intrauterine environment is assessed crudely by birth weight of the infant.
However, birth weight is not the sole indicator of intrauterine nutritional status (17). For
instance, low birth weight caused by under nutrition during gestation is defined as a birth
weight below 2500 grams or <10th percentile (18). However, birth weight does not
distinguish the impact of poor maternal nutrition or whether infants failed to thrive (17).
Even though some research suggests a relationship between birth weight and
development of disease in adulthood, the relationship remains equivocal (31-35). Other
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research (32) suggests inadequate nutrition during pregnancy may affect health in
adulthood indirectly. Consequently, the influence of birth weight on adult health is
paradoxical; both low and high birth weight are associated with increased incidences of
adult disease such as diabetes (13, 167, 184). To address these divergent views regarding
the relationship between an adverse intrauterine environment, we designed a study to
delineate the association between maternal weight and neonate birth weight and body
composition. Therefore, the purpose of this study was to compare infant body weight
and composition from mothers who had a normal pre-gravid BMI (<25 kg/m2) or whom
had an overweight/obese pre-gravid BMI (25 kg/m2).
Research Methods and Procedures
Participants
Participants were recruited by mass emails sent to the University of Oklahoma
Health Sciences Center, newspapers advertisements, announcements in birthing classes
and flyers placed at pediatric clinics in the Oklahoma City area. Testing occurred in
Children’s Hospital in Oklahoma City. This study was approved by the Institutional
Review Board for Human Participants at the University of Oklahoma Health Sciences.
All participants signed an informed consent and HIPPA prior to testing.
Participants included mothers and their infants who were healthy full-term
infants <35 days old. Inclusion criteria were: 1) healthy infants, defined as spending <3
days in the hospital after delivery, 2) gestational age >37 weeks and <42 weeks and, 3)
age of mother at the time of delivery between the ages of 18 to 45 years. Exclusion
criteria for the study included the following: 1) any tobacco use during pregnancy, 2)
excess alcohol consumption during pregnancy defined as >1 drink a week, 3) infants
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with presumed or known chromosomal or severe congenital abnormalities, and 4) infants
of mothers with diabetes (i.e. type 1, type 2 or gestational diabetes).
Maternal body weight before pregnancy, weight gain during pregnancy, total
family income and maximum weight reached during pregnancy were obtained by
interview during the consenting process, which occurred at the time of neonate testing.
Neonate birth weight and birth length were also self-reported by the mother. The
mother’s pre-gravid BMI was calculated using the participants self-reported body weight
prior to pregnancy and their height was measured at the visit.
Air-displacement Plethysmography (PEA POD®)
Infant length was measured using a length board. Infants were stretched out so
that his/her head remained stable but his/her legs were extended. The adjustable portion
of the stadiometer was placed against their outstretched feet. Length was recorded to the
nearest 0.1 centimeter. The Pea Pod® Body Composition System (Life Measurement
Instruments, Concord, CA) was used to measure body weight and body volume. The Pea
Pod® was calibrated before each test or once daily during testing days where multiple
tests were performed. A calibration cylinder with a known volume was used to calibrate
the chamber and a 5000 gram weight was used to calibrate the scale. Testing procedures
have been described in detail elsewhere (75). To assess body weight, the infant’s
clothing and diaper were removed. The infant was placed naked on the scale and a body
weight was obtained to the nearest 0.0001 kg. After body weight was measured, the
infant was placed inside the Pea Pod® wearing a wig cap and a body volume
measurement was performed. Assessment of the body volume required approximately 2
minutes. Body density was then converted to percentage of fat (%fat) using gender
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specific equations by Foman (169). At the completion of testing, body composition
variables were then calculated; relative fat (%fat), total fat mass, and fat-free mass.
Maternal Weight and Height
Mothers removed all loose fitting clothing and shoes before being weighed on a
physician’s balance beam scale (Detecto Scales, Webb City, MO) to the nearest 0.1 kg.
Height of the mother was obtained using a stadiometer (Accu-Hite Wall Stadiometer,
Seca Corp., Hanover, MD). Participants removed their shoes and centered their feet on
the stadiometer with their hands placed on her hips. After an inhalation, height was
measured to the nearest 0.1 centimeter.
Statistical Analyses
Descriptive statistics (means and standard deviations) were calculated for all
outcome variables (birth weight, %fat, total fat mass and fat-free mass) within both of
the two groups according to mother’s pre-gravid BMI status. The groups were compared
to determine if any differences existed between the two groups. For interval data,
independent t-tests were calculated and for nominal data, a chi-square test was
completed.
To determine whether birth weight and body composition, adjusted for infant age
at visit, differed based on pre-gravid BMI (2 levels: normal and overweight/obese),
analysis of covariance (ANCOVA) was performed. Stepwise multiple linear regression
analysis determined which maternal factors were related to infant outcome variables.
The dependent variables used in the model were: neonate birth weight, %fat, fat mass
and fat-free mass; independent variables were gestational age, infant age at testing,
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maternal pre-gravid body weight, BMI, maximum body weight, weight gain, gender and
socioeconomic status. The alpha level was set at P  0.05.
Results
Seventy-two women (33 with a normal pre-gravid BMI (<25 kg/m2) and 39 with
an overweight/obese (25 kg/m2) pre-gravid BMI) enrolled in the study. The majority of
the sample was Caucasian (80%), with the remainder comprised of African American
(3%), Native American (4%), Asian (1%), Hispanic (6%) with the remaining 6%
classifying themselves as other races.
The groups did not significantly differ in age, height, weight gain during
pregnancy, gender of infant, status of feeding (breast vs. formula), or family income
(Table 1). Pre-gravid body weight, BMI, maximum weight during pregnancy, and body
weight at the time of visit were significantly different between the two groups (Table 1).
Infants of mothers with a normal pre-gravid BMI had a greater gestational age
and birth length than infants from overweight/obese mothers P0.05 (Table 2).
ANCOVA controlled for maternal factors that potentially affect fetal growth and
subsequent neonate body weight and composition. Covariates investigated were
gestational age, infant age at testing, maternal pre-gravid body weight and BMI,
maximum body weight, weight gain, gender, and socioeconomic status. Only neonate
age at testing was significant. Therefore, anthropometric variables body weight and
composition data for infants from both the normal and overweight/obese groups were
adjusted for infant age at testing (Table 2). The groups did not differ for birth weight or
length, however differences between groups were found in infant body composition
variables. Offspring of the normal group had lower body fat and fat mass and greater fat-
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free mass than offspring of mothers who were overweight/obese (Table 2). Unadjusted
means for infant outcome variables are listed in Appendix D.
Multiple stepwise regression analysis assessed the relationship between maternal
factors to infant body weight and composition in the normal (Table 3) and
overweight/obese (Table 4) groups. We examined the two groups using separate
stepwise approaches entering gestational age, infant age at testing, maternal pre-gravid
body weight, BMI, maximum body weight, weight gain, gender, and socioeconomic
status as independent predictor variables. We examined separate models for each of the
four dependent variables: birth weight, %fat, fat mass, and fat-free mass as dependent
variables. In the analysis of birth weight, no significant correlations existed with any of
the independent predictor variables for either group. In the analysis of %fat for both the
normal and overweight/obese groups, the only significant association was with infant
age at testing (Tables 3 and 4). Lastly in the analysis, fat-free mass in the normal group
was associated with infant gender (Table 3). In the overweight/obese group, fat-free
mass was associated with feeding status, infant age at visit, and gestational age (Table
4).
Discussion
The primary purpose of this study was to better understand the impact of
maternal BMI on infant birth weight and body composition. Our main findings were that
infants born to mothers with a normal pre-gravid BMI had less fat mass and greater fat-
free mass than infants born to mothers who were overweight/obese.
Our study showed no difference in birth weight between groups. However,
numerous studies have reported maternal BMI and neonate birth weight having a
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positive linear relationship (28, 59, 160, 168, 176-178, 188-190). This association has
been shown in European samples as well. In an Austrian sample of 10,240 singleton
births, Kirchengast et al. (177) reported a positive relationship between pre-pregnancy
BMI and birth weight and in a Swedish sample Rossner and Ohlin (168) reported that
maternal weight gain and initial maternal body weight predicted infant birth weight. The
consensus in all of these studies clearly demonstrates a strong positive relationship
between maternal BMI and birth weight.
Our data showed no significant difference in birth weight between the two
groups; however, neonates from mothers with a normal pre-gravid BMI had significantly
less %fat, total fat mass, and more fat-free mass than neonates from overweight/obese
mothers. Similar results were reported by Sewell et al. (59) who showed no significant
difference in birth weight in offspring from mothers with a pre-gravid BMI <25 kg/m2
and a pre-gravid BMI 25 kg/m2. Their body composition data (determined by total
body electrical conductivity) revealed a significantly greater amount of fat mass and
%fat in the neonates from overweight/obese mothers though no difference in fat-free
mass was found. They concluded pre-gravid obesity played a significant role in infant fat
mass, but interestingly, not in fat-free mass (59).
To further refine the relationship between body composition and maternal BMI,
we performed multiple stepwise regression to determine which independent variables
were associated with the increased total fat mass and decreased fat-free mass in the
neonates born to mothers who were overweight/obese. In neonates from
overweight/obese mothers, the variable that explained the most variability in %fat was
the infant’s age at the time of the visit. Infant age at visit in our study ranged from 5 days
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up to 35 days while all testing for Sewell’s population occurred within 72 hours of birth
(59). It is unclear if they used infant age at the time of testing as an independent variable.
We also developed a model to examine which factors predicted fat-free mass. In
infants from normal mothers, infant gender was highly related to fat-free mass
accounting for 23% of the variance between the two variables. However, in
overweight/obese infants, the greatest predictors of fat-free mass were feeding status
(breast versus formula), infant age at visit and gestational age. This model accounted for
42% of the variance in fat-free mass.
Despite compelling epidemiological data, vigorous debate disputes the veracity
of the fetal origin hypothesis and its linking of maternal weight, neonate birth and future
disease risk (59, 191) (192). Generally speaking, it is accepted that maternal weight is
associated with birth weight (193), and evidence shows that the incidence of neonates
weighing >4,000 grams increases as mothers BMI increases from normal (8%) to
morbidly obese (15%) (194).
Perhaps the fetal origins hypothesis and the relationship between maternal weight
and their offspring is obfuscated because of a lack of accurate assessment tools available
to assess confounding variables, namely fat mass and fat-free mass. It is our theory that
fat mass and fat-free mass (lack there of) at birth, rather than body weight per se, is what
mediates the adult consequences of variations in fetal growth.
The implementation of body composition assessment in neonates is rare, partly
because of a lack of valid instruments. However, elegant work by Catalano (195) and
Sewell (59) has shown that 83% of the variability in birth weight is explained by fat-free
mass. For this reason that our study findings are unique and novel, because we studied
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not only birth weight but also body composition. However, more studies that use body
composition are needed to fully understand the role maternal weight plays on neonate
weight and the subsequent risk of future chronic diseases.
Future work is needed to expand our understanding of maternal pre-gravid
weight on infant outcomes. It would be ideal to assess maternal body composition prior
to or during pregnancy to clearly delineate the role of maternal nutrition on metabolic
disturbances in the offspring. Research has shown that in cases of gestational diabetes or
impaired glucose tolerance, the fetus is exposed to increased levels of nutrients resulting
in hyperglycemia, hyperinsulinemia. These exposures increase the risk of obesity in
childhood and adulthood (196). Furthermore, detailed and careful nutrient intake and
physical activity levels are needed to discern specific associations with the intent of
establishing cause and effect relationships. Rat models have shown that a diet high in
saturated fat during gestation resulted in offspring with abnormal vascular function and
altered plasma lipid and fatty acid content (52). 
In conclusion, infants born to overweight/obese mothers had a greater %fat and
fat mass and less fat-free mass than infants from mothers with a normal BMI. Though
provocative, further work taking a panoptic view is needed. This would be particularly
important for understanding the impact of maternal diet on neonate body weight and
composition.
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Table 1: Maternal demographics of the normal (<25 kg/m2) and overweight/obese
groups (25 kg/m2).
Normal
(N=33)
Overweight/
Obese
(N=39)
P
Value
Age at delivery (yrs) 27.9 ± 5.3 28.0 ± 5.6 0.94
Pre-gravid body weight (kg)† 58.9 ± 6.7 87.0 ± 21.6 0.000
Pre-gravid BMI (kg/m2)† 21.7 ± 1.9 31.8 ± 6.9 0.000
Maximum weight during
pregnancy† 73.5 ± 8.3 98.5 ± 20.4 0.000
Weight gained during pregnancy† 14.8 ± 4.3 13.0 ± 4.7 0.82
Body weight at visit (kg) 66.1 ± 8.4 92.4 ± 22.4 0.000
Height at visit (cm) 164.5 ± 5.3 164.9 ± 7.0 0.75
Income (%) 0.32
<$30,000 27% 46%
$30,001 to $60,000 31% 22%
$60,001 to $90,000 18% 8%
>$90,000 24% 24%
Mean ± standard deviation
†Self report by the mother
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Table 2: Demographics and neonate outcome variables of neonates from normal (<25
kg/m2) and overweight/obese study groups (25 kg/m2). Differences are based on results
of analysis of covariance and means of infant outcome variables were adjusted for infant
age at visit.
Normal
(N=33)
Overweight/
Obese (N=39) P Value
Male gender (%) 42% 44% 0.56
Breast fed (%) 79% 72% 0.40
Gestational age (weeks)† 39.5 ± 1.2 38.9 ± 1.0 0.03
Infant age at time of testing
(days)† 19.5 ± 8.5 19.8 ± 9.3 0.91
Infant Out Come Variables
Birth length (cm)† 50.7 ± 2.6 49.6 ± 2.6 0.08
Birth weight (g)† 3433.0 ± 396.3 3368.0 ± 399.6 0.44
%fat 12.5 ± 4.2 13.6 ± 4.3 0.000
Fat mass (g) 414.1 ± 264.2 448.3 ± 262.2 0.04
Fat-free mass (g) 3310.5 ± 344.6 3162.2 ± 343.4 0.03
Mean ± standard deviation
†Self report by the mother
65
Table 3: Multiple stepwise regression analysis for factors that affected infant outcome
variables in 33 women with a pre-gravid BMI <25 kg/m2.
Factor r2  r2 P Value
%fat
Infant age at visit 0.29 - 0.003
Fat-free mass
Infant gender 0.23 - 0.000
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Table 4: Multiple stepwise regression analysis for factors that affected infant outcome
variables in 39 women with pre-gravid BMI 25 kg/m2.
Factor r2  r2 P Value
%fat
Infant age at visit 0.28 - 0.000
Fat-free mass
Feeding status 0.22 - 0.007
Infant age at visit 0.31 0.09 0.007
Gestational age 0.42 0.11 0.021
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CONSENT FORM
UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER
Study Title: “Prenatal Maternal Weight Status and Its Impact on Fetal
Birth Weight and Composition”
Principal Investigator: David A. Fields, PhD.
This is a research study. Research studies involve only individuals who choose to
participate. Please take your time to make your decision, and do not make your
decision until you feel you have all the information you need about the project.
Participating in this study, the use of the term “You” refers to “You and Your Child”
and addresses both the participant and the parent or legally authorized representative.
Why Have I Been Asked To Participate In This Study?
You are being asked to take part in this study because you gave birth to a baby within
the last 45 days.
Why Is This Study Being Done?
This study is being done to help determine what, if any, impact your weight and
diabetic status before becoming pregnant has on your baby’s weight and body
composition.
How Many People Will Take Part In The Study?
A total of 180 mother-baby pairs will take part in the study.
What Is Involved In The Study?
Health Status: We will obtain some preliminary information regarding your health
from your physician and medical record chart. This will include recording your age,
height, pre-pregnancy weight, and race. We will not be obtaining your current weight.
A medical history will be taken on your baby and your baby’s weight, length, and
head circumference will also be measured.
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Picture of the Pea Pod.
Body Composition Testing: The amount of fat your baby has
will be measured in an instrument called a Pea Pod. Your baby
will be placed naked inside the Pea Pod for approximately 3
minutes. Your baby will lie in an enclosed chamber, but there
is a viewing window where you can see your baby (and your
baby can see you) for the entire test. It is a clean, warm,
comfortable environment for your baby. At no time will you
ever be away from your baby or be unable to see your baby.
The Pea Pod is totally painless for your baby and similar to
being placed on his/her back in a small bassinette.
Food Recall: You will be asked the foods and drinks they ate
over the last four days and for the immediate past twenty-four
hours. Your food recall will be sent to the University of
Alabama in Birmingham for analysis (your recall will be unidentified).
Optional Testing
Blood Draw: During your third trimester of pregnancy 10 cc of blood will be drawn
from the mother. This will be done to measure glucose levels and markers of
inflammation, both of which could play a role in your infants body weight and
composition. Your blood will be sent to the University of Alabama in Birmingham for
analysis (your blood will be unidentified). This blood draw is optional. You still can
participate in the study without giving blood.
_____ Yes, I agree to have blood drawn.
_____ No, I do not agree to have blood drawn
How Long Will It Take?
We anticipate it will take approximately 20 to 30 minutes to obtain the information on
you and your baby and to perform the Pea Pod testing on your baby. You will not have
to do anything else for the study or come back at a later date.
Where Will I Have To Go?
You and your baby will go to The Children’s Hospital at OU Medical Center on the
Health Sciences Center Campus.
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What Are The Risks of The Study?
Risks / Discomforts: There are very minimal risks and discomforts involved during
your participation in this research study. All research procedures will be conducted by
qualified researchers and medical personnel. The potential risk and discomforts
associated with the research study are listed below:
Body Composition Test: Your infant may cry upon being placed in the Pea Pod due to
physical separation from you.
What Are The Benefits to Taking Part in The Study?
There are no benefits in participating in this study. The information you contribute will
assist with determining the possible influence of mother’s body status before becoming
pregnant on the body composition of her infant. We hope that these studies will help us
determine the factors that contribute to a child being underweight, normal weight, or
overweight.
What Other Options Are There?
Instead of being in this study, you have the option to not participate.
What About Confidentiality?
Efforts will be made to keep your personal information confidential. You will not be
identifiable by name or description in any reports or publications about this study.
We cannot guarantee absolute confidentiality. Your personal information may be
disclosed if required by law. You will be asked to sign a separate authorization form
for use or sharing of your protected health information. There are organizations that
may inspect and/or copy your research record for quality assurance and data analysis.
These organizations include the OUHSC Institutional Review Board.
What Are the Costs?
Transportation will be your only cost. Parking is free.
Will I be paid for the Study?
You will be reimbursed with a $50 Simon Visa Gift Card for participating in the
study.
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What Are My Rights As A Participant?
Taking part in this study is voluntary. You may choose not to take part or may leave
the study at any time. If you agree to take part and then decide against it, you can
withdraw for any reason. Leaving the study will not result in any penalty or loss of
benefits that you would otherwise receive. You understand that you have the right to
access the medical information that has been collected about you as a part of this
research study. However, you agree that you may not have access to this medical
information until the entire research study has completely finished and you consent to
this temporary restriction. We will tell you about any new information that may affect
your health, welfare or willingness to stay in this study.
Whom Do I call If I have Questions or Problems?
If you have questions about the study or have a research–related injury, contact David
A. Fields, Ph.D. at (405) 271-8001 extension 43083, (405) 271-6764, or at (405) 325-
7358. For questions regarding your rights as a research subject, contact the OUHSC
Director, Human Research Participant Protection Program at (405) 271-2045.
Signature:
By signing this form, you are agreeing to participate in this research study under the
conditions described. You have not given up any of your legal rights or released any
individual or institution from liability for negligence. You have been given an
opportunity to ask questions. You will be given a copy of this consent document.
Your signature indicates that you have decided to participate, that you have read (or
been read) the information provided above, and that you have received a copy of this
consent form.
____________
Infant Printed Name Date
_ ___________
Mother Signature Parent (Mother) Printed Name Date
_ ___________
Father Signature Parent (Mother) Printed Name Date
Person Obtaining Consent Date
APPROVED APPROVAL EXPIRES
MAY 0 52006 APR 3 0 7007 I
OUHSCIRB OUHSCIRB
91
IRB No.: 12828
AUTHORIZATION TO USE or DISCLOSE
PROTECTED HEALTH INFORMATION FOR RESEARCH
An additional Informed Consent Document for Research Participation may also be
required.Form 2 must be used for research involving psychotherapy notes.
Title of Research Project: Prenatal Maternal Weight Status and its Impact on Fetal Birth Weight and Composition
Leader of Research Team: David A. Fields, Ph.D
Address: OUCP Diabetes & Endocrinology, 940 NE 13th, CH 2B2426, OKC, OK
73104
Phone Number: (405) 271-6764 ext: 43083 or (405) 325-7358
If you decide to join this research project, University of Oklahoma Health Sciences Center (OUHSC) researchers may use or
share (disclose) information about you that is considered to be protected health information for their research. Protected health
information will be called private information in this Authorization.
Private Information To Be Used or Shared. Federal law requires that researchers
get your permission (authorization) to use or share your private information. If you
give permission, the researchers may use or share your and your baby’s private
information with the people identified in this authorization any private information
related to this research from your medical records and from any test results.
Information, used or shared, may include all information relating to any tests,
procedures, surveys, or interviews as outlined in the consent form, medical records
and charts, name, address, telephone number, date of birth, race, and government-
issued identification number.
Purposes for Using or Sharing Private Information. If you give permission, the researchers may use your private information to
better understand how maternal weight prior to pregnancy impacts the birth weight and composition of their offspring.
Other Use and Sharing of Private Information. If you give permission, the
researchers may also use your private information to develop new procedures or
commercial products. They may share your private information with the research
sponsor, the OUHSC Institutional Review Board, auditors and inspectors who check
the research, and government agencies such as the Food and Drug Administration
(FDA) and the Department of Health and Human Services (HHS). The researchers
may also share your private information with Drs. Kenneth C. Copeland and Casey
Hester and their research team at the University of Oklahoma Health Science Center.
Additionally, the unidintified blood and food recalls will be sent to the University of
Alabama in Birmingham.
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Confidentiality. Although the researchers may report their findings in scientific journals or meetings, they will not identify you in
their reports. The researchers will try to keep your information confidential, but confidentiality is not guaranteed. Any person or
organization receiving the information based on this authorization could re-release the information to others and federal law would
no longer protect it.
YOU MUST UNDERSTAND THAT YOUR PROTECTED HEALTH INFORMATION MAY INCLUDE
INFORMATION REGARDING ANY CONDITIONS CONSIDERED AS A COMMUNICABLE OR VENEREAL
DISEASE WHICH MAY INCLUDE, BUT ARE NOT LIMITED TO, DISEASES SUCH AS HEPATITIS, SYPHILIS,
GONORRHEA, AND HUMAN IMMUNODEFICIENCY VIRUS ALSO KNOWN AS ACQUIRED IMMUNE
DEFICIENCY SYNDROME (AIDS).
Voluntary Choice. The choice to give OUHSC researchers permission to use or share your private information for their research
is voluntary. It is completely up to you. No one can force you to give permission. However, you must give permission for
OUHSC researchers to use or share your private health information if you want to participate in the research and if you revoke
your authorization, you can no longer participate in this study.
Refusing to give permission will not affect your ability to get routine treatment or health care from OUHSC.
Revoking Permission. If you give the OUHSC researchers permission to use or
share your private information, you have a right to revoke your permission whenever
you want. However, revoking your permission will not apply to information that the
researchers have already used, relied on, or shared.
End of Permission. Unless you revoke it, permission for OUHSC researchers to use
or share your private information for their research will “never end”. You may revoke
your permission at any time by writing to:
Privacy Official
University of Oklahoma Health Sciences Center
PO Box 26901, Oklahoma City, OK 73190
If you have questions call: (405) 271-2511
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Giving Permission. By signing this form, you give OUHSC and OUHSC’s
researchers led by David A. Fields, Ph.D., permission to share your private
information for the research project called “Prenatal Maternal Weight Status and
its Impact on Fetal Birth Weight and Composition”.
Patient/Subject Name: _______________________
__________________________________________ _____________
Signature of Patient-Subject Date
or Parent if subject is a child
Or
__________________________________________ _____________
Signature of Legal Representative** Date
**If signed by a Legal Representative of the Patient-Subject, provide a description of
the relationship to the Patient-Subject and the Authority to Act as Legal Representative:
______________________________________________________________________
_
OUHSC may ask you to produce evidence of your relationship.
A signed copy of this form must be given to the Patient-Subject or the Legal
Representative at the time this signed form is provided to the researcher or his
representative.
IRB No.: 12828
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Participant ID: CA- __ __ __- __ __
Group ID: _____________________
INITIAL VISIT
ELIGIBILITY
Review potential participant eligibility using the standard screening script and
Recruitment database. Use gestation calculator and enter answers below. Answer
summary questions.
Baby’s Name:
Today’s date: / / (mm/dd/yy)
First day of last menstrual period: / / (mm/dd/yy)
Estimated due date: / / (mm/dd/yy)
Actual date of birth: / / (mm/dd/yy)
Length of gestation: / weeks / days
Today’s age: days
SCREENING
Check one answer for each question: YES NO
Healthy male or female full term infant with gestational age of 37
weeks and <42 weeks?
Infant discharged from the hospital 28 days of delivery?
Mother age at time of delivery between 18-45 years old?
Did infant stay in the hospital >4 days?
Did mother smoke during pregnancy/lactation?
Did mother use alcohol (>1 drink /week) during pregnancy?
Does infant have a known chromosomal or severe congenital
abnormality?
Do mom / baby meet all inclusion criteria (no shaded answers)?
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Check one answer for each question: YES NO
Did mom have type 1, type 2 diabetes or gestational diabetes during
pregnancy (circle which one)?
Was diabetes present before pregnancy?
Did mother have pre-eclampsia?
Participating in the “Normative” study?
BABY’S FAMILY HISTORY (Mother, Father and
Grandparents)
YES NO
Diabetes (list relative and age of onset)
Heart Disease (list relative and age of onset)
Hypertension (list relative and age of onset)
Polycystic ovaries, infertility, hirsutism (list relative and age of onset)
Thyroid Disease (list relative and age of onset)
Smoking in immediate family (list relative and age of onset)
INFORMED CONSENT
In a verbal discussion, the parent(s) was informed of all aspects of the study
using the written informed consent and HIPAA documents. The parent(s) was
then given time to privately re-read the informed consent and HIPAA
documents. The parent(s) was given an opportunity to ask questions. All
questions were answered prior to signing both documents. A signed copy of
both forms was given to the parent(s).
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DIET ASSESSMENT
How often does baby nurse?
How many times per day (24 hours) does baby nurse?
Does baby usually nurse on one side or both at each feed?
How long does baby nurse each time? Minutes
DEMOGRAPHICS
Mother’s Ethnic Background: ______________________
Father’s Ethnic Background: ______________________
Address:
City, State, Zip
Phone(s): Type:
Type:
E-mail Address:
Total Family Income: (per year)
Infant:
Sex: Male Female
Race: White
Black or African American
American Indian / Alaska Native
Asian
Native Hawaiian / Pacific Islander
Other:
Two or more races:
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Mother
Self-reported pre-pregnancy weight:
Self-reported weight gain during pregnancy:
Age at birth:
Today Measure 1
Weight (kg)
Height (cm)
Infant
Today Measure 1
Weight (kg)
Length (cm)
Head circumference (cm)
PeaPod
Obtained, copy of results placed in study file
Not obtained. Reason:
Check any that apply:
Calm Crying
Urine Bowel Movement
Comments:
Check one answer for each question: YES NO
4 day food recall completed?
24 Hour Food Recall Completed?
Provide compensation for today’s visit:
Compensation:
APPROVED APPROVAL EXPIRES
MAY 0 52006 APR 3 0 7007 I
OUHSCIRB OUHSCIRB
99
APPENDIX D
(Unadjusted Infant Outcome Variables)
100
Normal
(N=33)
Overweight/
Obese (N=39)
Birth weight (g) 3433.8 ± 333.7 3367.0 ± 446.8
%fat 12.5 ± 5.0 13.7 ± 5.1
Fat mass (g) 412.7 ± 255.5 449.1 ± 284.5
Fat-free mass (g) 3308.5 ± 313.8 3162.8 ± 382.6
